Tus Pharmaceutical Group Co Ltd (000590) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.24 Million ≈ $327.43K USD) by net assets (CN¥585.85 Million ≈ $85.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tus Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Tus Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.
Tus Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Y mAbs Therapeutics
NASDAQ:YMAB
|
0.019x |
|
Lim Seong Hai Capital Berhad
KLSE:0351
|
0.073x |
|
Refex Industries Limited
NSE:REFEX
|
0.058x |
|
Cryoport Inc
NASDAQ:CYRX
|
0.002x |
|
Chemplast Sanmar Limited
NSE:CHEMPLASTS
|
0.039x |
|
Cedar Development Co Ltd
SHE:002485
|
-0.045x |
|
Hamborner REIT AG
XETRA:HABA
|
0.031x |
|
Jiangsu Holly Corp
SHG:600128
|
0.038x |
Annual Cash Flow Conversion Efficiency for Tus Pharmaceutical Group Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Tus Pharmaceutical Group Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥601.23 Million ≈ $87.98 Million |
CN¥17.39 Million ≈ $2.54 Million |
0.029x | +174.17% |
| 2023-12-31 | CN¥728.20 Million ≈ $106.56 Million |
CN¥-28.39 Million ≈ $-4.16 Million |
-0.039x | -150.29% |
| 2022-12-31 | CN¥702.49 Million ≈ $102.80 Million |
CN¥54.47 Million ≈ $7.97 Million |
0.078x | +109.99% |
| 2021-12-31 | CN¥682.32 Million ≈ $99.85 Million |
CN¥25.20 Million ≈ $3.69 Million |
0.037x | -53.74% |
| 2020-12-31 | CN¥644.88 Million ≈ $94.37 Million |
CN¥51.48 Million ≈ $7.53 Million |
0.080x | +70.04% |
| 2019-12-31 | CN¥622.16 Million ≈ $91.04 Million |
CN¥29.21 Million ≈ $4.27 Million |
0.047x | +4059.95% |
| 2018-12-31 | CN¥579.72 Million ≈ $84.83 Million |
CN¥654.24K ≈ $95.74K |
0.001x | +100.74% |
| 2017-12-31 | CN¥583.33 Million ≈ $85.36 Million |
CN¥-89.14 Million ≈ $-13.04 Million |
-0.153x | -24.06% |
| 2016-12-31 | CN¥263.96 Million ≈ $38.63 Million |
CN¥-32.51 Million ≈ $-4.76 Million |
-0.123x | +58.14% |
| 2015-12-31 | CN¥205.79 Million ≈ $30.11 Million |
CN¥-60.56 Million ≈ $-8.86 Million |
-0.294x | -6.42% |
| 2014-12-31 | CN¥184.11 Million ≈ $26.94 Million |
CN¥-50.91 Million ≈ $-7.45 Million |
-0.277x | -1907.88% |
| 2013-12-31 | CN¥269.51 Million ≈ $39.44 Million |
CN¥4.12 Million ≈ $603.20K |
0.015x | -62.93% |
| 2012-12-31 | CN¥478.58 Million ≈ $70.03 Million |
CN¥19.75 Million ≈ $2.89 Million |
0.041x | -53.10% |
| 2011-12-31 | CN¥350.83 Million ≈ $51.34 Million |
CN¥30.87 Million ≈ $4.52 Million |
0.088x | -71.13% |
| 2010-12-31 | CN¥278.88 Million ≈ $40.81 Million |
CN¥84.98 Million ≈ $12.43 Million |
0.305x | +106.35% |
| 2009-12-31 | CN¥231.22 Million ≈ $33.84 Million |
CN¥34.14 Million ≈ $5.00 Million |
0.148x | +36.63% |
| 2008-12-31 | CN¥322.78 Million ≈ $47.23 Million |
CN¥34.89 Million ≈ $5.10 Million |
0.108x | -51.20% |
| 2007-12-31 | CN¥307.22 Million ≈ $44.96 Million |
CN¥68.04 Million ≈ $9.96 Million |
0.221x | +357.48% |
| 2006-12-31 | CN¥271.26 Million ≈ $39.69 Million |
CN¥-23.33 Million ≈ $-3.41 Million |
-0.086x | -141.28% |
| 2005-12-31 | CN¥268.54 Million ≈ $39.30 Million |
CN¥55.96 Million ≈ $8.19 Million |
0.208x | +15.06% |
| 2004-12-31 | CN¥267.57 Million ≈ $39.15 Million |
CN¥48.46 Million ≈ $7.09 Million |
0.181x | +292.13% |
| 2003-12-31 | CN¥259.16 Million ≈ $37.92 Million |
CN¥-24.43 Million ≈ $-3.57 Million |
-0.094x | -128.08% |
| 2002-12-31 | CN¥280.91 Million ≈ $41.11 Million |
CN¥94.30 Million ≈ $13.80 Million |
0.336x | +283.41% |
| 2001-12-31 | CN¥278.65 Million ≈ $40.78 Million |
CN¥-51.00 Million ≈ $-7.46 Million |
-0.183x | -944.87% |
| 2000-12-31 | CN¥380.02 Million ≈ $55.61 Million |
CN¥8.23 Million ≈ $1.20 Million |
0.022x | +172.82% |
| 1999-12-31 | CN¥347.80 Million ≈ $50.89 Million |
CN¥-10.35 Million ≈ $-1.51 Million |
-0.030x | -305.60% |
| 1998-12-31 | CN¥268.78 Million ≈ $39.33 Million |
CN¥3.89 Million ≈ $569.06K |
0.014x | -- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food in China. It operates through the Production and Sales of Traditional Chinese Medicine; Production and Sales of Western Medicine; and Other Operations segments. The company offers prescription and over-the-counter drugs, such as tonic and heal… Read more